Cargando…
Antagonistic Effects of CAPE (a Component of Propolis) on the Cytotoxicity and Genotoxicity of Irinotecan and SN38 in Human Gastrointestinal Cancer Cells In Vitro
The incidence of gastrointestinal cancers is increasing every year. Irinotecan (CPT-11), a drug used in the treatment of colorectal cancer and gastric cancer, is metabolized by carboxylesterases to an active metabolite, SN-38, which is more cytotoxic. CAPE (caffeic acid phenethyl ester) is an active...
Autores principales: | Gajek, Gabriela, Marciniak, Beata, Lewkowski, Jarosław, Kontek, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038052/ https://www.ncbi.nlm.nih.gov/pubmed/32033066 http://dx.doi.org/10.3390/molecules25030658 |
Ejemplares similares
-
Synthesis, fluorescence properties and the promising cytotoxicity of pyrene–derived aminophosphonates
por: Lewkowski, Jarosław, et al.
Publicado: (2016) -
Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
por: Kciuk, Mateusz, et al.
Publicado: (2020) -
Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro
por: Bukowski, Karol, et al.
Publicado: (2022) -
An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells
por: Yashiro, M, et al.
Publicado: (2011) -
Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38
por: Mathijssen, R H J, et al.
Publicado: (2002)